Page last updated: 2024-09-04

ly 311727 and Atherosclerosis

ly 311727 has been researched along with Atherosclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blache, D; Gautier, T; Lagrost, L; Tietge, UJ	1

Other Studies

1 other study(ies) available for ly 311727 and Atherosclerosis

Article	Year
Activated platelets contribute to oxidized low-density lipoproteins and dysfunctional high-density lipoproteins through a phospholipase A2-dependent mechanism. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2012, Volume: 26, Issue:2 Topics: Animals; Atherosclerosis; Blood Platelets; Enzyme Inhibitors; Female; Group II Phospholipases A2; Humans; In Vitro Techniques; Indoles; Lipoproteins, HDL; Lipoproteins, LDL; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Platelet Activation; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Ticlopidine	2012

Article

Year

Activated platelets contribute to oxidized low-density lipoproteins and dysfunctional high-density lipoproteins through a phospholipase A2-dependent mechanism.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2012, Volume: 26, Issue:2

Topics: Animals; Atherosclerosis; Blood Platelets; Enzyme Inhibitors; Female; Group II Phospholipases A2; Humans; In Vitro Techniques; Indoles; Lipoproteins, HDL; Lipoproteins, LDL; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Platelet Activation; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Ticlopidine

2012